rs1484835507

Variant summary

Our verdict is Uncertain significance. The variant received 0 ACMG points: 2P and 2B. PM2BP4BS1_Supporting

The NM_003072.5(SMARCA4):​c.4802G>A​(p.Arg1601Gln) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000357 in 1,401,898 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Conflicting classifications of pathogenicity (no stars). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R1601W) has been classified as Uncertain significance.

Frequency

Genomes: not found (cov: 33)
Exomes 𝑓: 0.0000036 ( 0 hom. )

Consequence

SMARCA4
NM_003072.5 missense

Scores

1
11
6

Clinical Significance

Conflicting classifications of pathogenicity criteria provided, conflicting classifications U:4B:1

Conservation

PhyloP100: 3.19

Publications

6 publications found
Variant links:
Genes affected
SMARCA4 (HGNC:11100): (SWI/SNF related, matrix associated, actin dependent regulator of chromatin, subfamily a, member 4) The protein encoded by this gene is a member of the SWI/SNF family of proteins and is similar to the brahma protein of Drosophila. Members of this family have helicase and ATPase activities and are thought to regulate transcription of certain genes by altering the chromatin structure around those genes. The encoded protein is part of the large ATP-dependent chromatin remodeling complex SNF/SWI, which is required for transcriptional activation of genes normally repressed by chromatin. In addition, this protein can bind BRCA1, as well as regulate the expression of the tumorigenic protein CD44. Mutations in this gene cause rhabdoid tumor predisposition syndrome type 2. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, May 2012]
SMARCA4 Gene-Disease associations (from GenCC):
  • Coffin-Siris syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, ClinGen, Illumina
  • intellectual disability, autosomal dominant 16
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Labcorp Genetics (formerly Invitae), Ambry Genetics
  • rhabdoid tumor predisposition syndrome 2
    Inheritance: AD Classification: DEFINITIVE, STRONG Submitted by: G2P, Ambry Genetics, Genomics England PanelApp, ClinGen, Labcorp Genetics (formerly Invitae)
  • otosclerosis
    Inheritance: AD Classification: STRONG Submitted by: PanelApp Australia
  • uterine corpus sarcoma
    Inheritance: AR Classification: MODERATE Submitted by: Genomics England PanelApp
  • familial rhabdoid tumor
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • hereditary nonpolyposis colon cancer
    Inheritance: Unknown Classification: LIMITED Submitted by: ClinGen

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Uncertain_significance. The variant received 0 ACMG points.

PM2
Very rare variant in population databases, with high coverage;
BP4
Computational evidence support a benign effect (MetaRNN=0.31096333).
BS1
Variant frequency is greater than expected in population afr. GnomAdExome4 allele frequency = 0.00000357 (5/1401898) while in subpopulation AFR AF = 0.000126 (4/31712). AF 95% confidence interval is 0.0000424. There are 0 homozygotes in GnomAdExome4. There are 2 alleles in the male GnomAdExome4 subpopulation. Median coverage is 33. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_003072.5. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SMARCA4
NM_001387283.1
MANE Plus Clinical
c.4898G>Ap.Arg1633Gln
missense
Exon 35 of 36NP_001374212.1Q9HBD4
SMARCA4
NM_003072.5
MANE Select
c.4802G>Ap.Arg1601Gln
missense
Exon 34 of 35NP_003063.2
SMARCA4
NM_001128849.3
c.4898G>Ap.Arg1633Gln
missense
Exon 35 of 36NP_001122321.1Q9HBD4

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
SMARCA4
ENST00000646693.2
MANE Plus Clinical
c.4898G>Ap.Arg1633Gln
missense
Exon 35 of 36ENSP00000495368.1Q9HBD4
SMARCA4
ENST00000344626.10
TSL:1 MANE Select
c.4802G>Ap.Arg1601Gln
missense
Exon 34 of 35ENSP00000343896.4P51532-1
SMARCA4
ENST00000643549.1
c.4808G>Ap.Arg1603Gln
missense
Exon 34 of 35ENSP00000493975.1A0A2R8Y4P4

Frequencies

GnomAD3 genomes
Cov.:
33
GnomAD2 exomes
AF:
0.00000632
AC:
1
AN:
158124
AF XY:
0.00
show subpopulations
Gnomad AFR exome
AF:
0.000115
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000357
AC:
5
AN:
1401898
Hom.:
0
Cov.:
33
AF XY:
0.00000289
AC XY:
2
AN XY:
691752
show subpopulations
African (AFR)
AF:
0.000126
AC:
4
AN:
31712
American (AMR)
AF:
0.00
AC:
0
AN:
35880
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
25190
East Asian (EAS)
AF:
0.00
AC:
0
AN:
35882
South Asian (SAS)
AF:
0.00
AC:
0
AN:
79532
European-Finnish (FIN)
AF:
0.00
AC:
0
AN:
49286
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
5696
European-Non Finnish (NFE)
AF:
9.25e-7
AC:
1
AN:
1080582
Other (OTH)
AF:
0.00
AC:
0
AN:
58138
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.475
Heterozygous variant carriers
0
0
1
1
2
2
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
Cov.:
33
Alfa
AF:
0.00
Hom.:
0
Bravo
AF:
0.0000113

ClinVar

ClinVar submissions
Significance:Conflicting classifications of pathogenicity
Revision:criteria provided, conflicting classifications
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
2
-
Rhabdoid tumor predisposition syndrome 2 (2)
-
-
1
Hereditary cancer-predisposing syndrome (1)
-
1
-
Intellectual disability, autosomal dominant 16 (1)
-
1
-
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
0.45
BayesDel_addAF
Uncertain
0.058
T
BayesDel_noAF
Benign
-0.15
CADD
Pathogenic
27
DANN
Pathogenic
1.0
DEOGEN2
Benign
0.37
T
Eigen
Uncertain
0.27
Eigen_PC
Uncertain
0.30
FATHMM_MKL
Uncertain
0.97
D
LIST_S2
Uncertain
0.93
D
M_CAP
Uncertain
0.24
D
MetaRNN
Benign
0.31
T
MetaSVM
Uncertain
0.29
D
MutationAssessor
Benign
0.69
N
PhyloP100
3.2
PrimateAI
Uncertain
0.76
T
PROVEAN
Benign
-1.3
N
REVEL
Uncertain
0.41
Sift
Uncertain
0.018
D
Sift4G
Benign
0.20
T
Polyphen
0.94
P
Vest4
0.32
MutPred
0.14
Gain of methylation at K1630 (P = 0.0951)
MVP
0.75
MPC
1.4
ClinPred
0.78
D
GERP RS
3.4
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
2.1
Varity_R
0.52
gMVP
0.74
Mutation Taster
=70/30
polymorphism

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs1484835507; hg19: chr19-11170754; COSMIC: COSV60790665; COSMIC: COSV60790665; API